NASDAQ · Medical - Instruments & Supplies

LMAT (LMAT) Stock

$79.00 -25.32% NASDAQ: LMAT Healthcare

Valuation

MetricValue
Price$79.00
Market Cap$1.81B
P/E Ratio35.74
P/B Ratio5.63
P/S Ratio8.68
EPS (TTM)$2.72
52-Week High$118.01
52-Week Low$78.35
Dividend Yield0.87%

Financials & Margins

MetricValue
ROE16.55%
ROA7.20%
ROCE17.26%
Gross Margin71.33%
Operating Margin26.71%
Net Margin24.35%
Debt/Equity0.47
Current Ratio14.32

Annual Financials (USD)

Metric20212022202320242025
Revenue$154.0M$162.0M$193.0M$220.0M$250.0M
Operating Profit$36.0M$27.0M$37.0M$52.0M$68.0M
Net Profit$27.0M$21.0M$30.0M$44.0M$58.0M
EPS$1.25$0.93$1.34$1.93$2.52
Op Margin23.6%16.6%19.0%23.8%27.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$293.0M$310.0M$347.0M$552.0M$616.0M
Total Liabilities$39.0M$42.0M$49.0M$215.0M$222.0M
Cash$14.0M$19.0M$24.0M$26.0M$28.0M
Borrowings$16.0M$17.0M$19.0M$186.0M$186.0M

Latest News

LMAT: Raising target price to $111.00 Argus Research · Jul 22, 2026 LeMaitre Will Announce Second Quarter 2026 Earnings Results on August 4, 2026 GlobeNewswire · Jul 14, 2026 1 Cash-Producing Stock Worth Your Attention and 2 Facing Headwinds StockStory · Jul 10, 2026 1 High-Flying Stock to Target This Week and 2 Facing Headwinds StockStory · Jul 2, 2026 1 Russell 2000 Stock with Exciting Potential and 2 We Find Risky StockStory · Jun 29, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$35.0M$25.0M$37.0M$44.0M$81.0M
Investing Cash Flow$-66.0M$-14.0M$-32.0M$-207.0M$-72.0M
Financing Cash Flow$-1.0M$-2.0M$-1.0M$-3.0M$-3.0M
Net Cash Flow$-13.0M$5.0M$5.0M$1.0M$3.0M
Free Cash Flow$30.0M$22.0M$29.0M$37.0M$74.0M

Valuation & Return Ratios

MetricValue
PEG Ratio3.07
EV / EBITDA25.96
FCF Yield3.56%
Quick Ratio12.20
Interest Coverage13.60
Return 1Y24.04%
Return 3Y59.86%
Return 5Y89.10%

Ownership

Insiders Held6.51%
Institutions Held100.69%
Institutions Float Held107.70%
Institutional HolderSharesReport Date
Blackrock Inc.3,144,1512026-03-31
Conestoga Capital Advisors, LLC1,476,8132026-03-31
First Trust Advisors LP998,0712026-03-31
Congress Asset Management Co963,7062026-06-30
Vanguard Capital Management LLC912,0582026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACHC $30.95 -3.99% 14.92 $2.88B 0.00%
ATRC $38.72 +2.54% 80.24 $1.97B 0.00%
AVAH $9.29 -0.48% 5.98 $2.02B 0.00%
HAE $83.60 -2.08% 37.62 $3.80B 0.00%
INSP $50.93 +3.54% 8.73 $1.47B 0.00%

About LMAT

LMAT stock trades at $79.00 with a market capitalization of $1.81B. The stock is valued at a price-to-earnings (P/E) ratio of 35.74, price-to-book of 5.63, price-to-sales of 8.68. Over the past 52 weeks the stock has ranged between $78.35 and $118.01, and currently trades 33.1% below its 52-week high. It pays a dividend yielding 0.87%.

On profitability, LMAT generates a return on equity (ROE) of 16.55%, above the typical market average, return on capital employed of 17.26%, an operating margin of 26.71%, a net profit margin of 24.35%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides